
Selective laser trabeculoplasty (SLT) is regaining attention due to promising findings from the Laser in Glaucoma and Ocular Hypertension Trial. As a drug-free initial treatment for glaucoma, SLT addresses issues like adherence and persistence. A narrative review explores SLT's utility across diverse glaucoma subtypes, emphasizing its efficacy and benefits. Despite evidence supporting SLT, questions linger about its long-term effects and potential retreatment needs. The review aims to inform clinicians about SLT's impact, guiding treatment decisions and optimizing patient outcomes while highlighting therapeutic protocols. It offers clarity on SLT's role in glaucoma management and underscores the importance of tailored treatment plans.
Like
Save
Share